Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES): Optic Neuritis Incidence Between 2015-2020

Camilo Andrés Rodríguez-Rodríguez; Carlos Cifuentes-González; Germán Mejía-Salgado; Juan Manuel Garzón-Dangond; Angie Vanessa Verbel-Yaneth; Sofia Machado-Galindo; Danna Lesley Cruz-Reyes; Alejandra de-la-Torre

doi:10.1080/09273948.2023.2295538

Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES): Optic Neuritis Incidence Between 2015-2020

Título traducido de la contribución: Estudio Epidemiológico Colombiano de Enfermedades Inflamatorias Oculares (COIDES): Incidencia de la neuritis óptica entre 2015 y 2020

Camilo Andrés Rodríguez-Rodríguez, Carlos Cifuentes-González, Germán Mejía-Salgado, Juan Manuel Garzón-Dangond, Angie Vanessa Verbel-Yaneth, Sofia Machado-Galindo, Danna Lesley Cruz-Reyes, Alejandra de-la-Torre

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

Resumen

Propósito: Estimar la incidencia de Neuritis Óptica (ON) en Colombia a partir de los datos del registro nacional de salud entre el 1 de enero de 2015 y el 31 de diciembre de 2020.

Métodos: Se realizó un estudio de base poblacional utilizando el Sistema Integrado de Información de Protección Social del Ministerio de Salud de Colombia y el código de la Clasificación Internacional de Enfermedades-10 para ON para estimar la incidencia de ON entre 2015 y 2020. También se evaluó el impacto del bloqueo COVID-19 sobre la epidemiología de la enfermedad en 2020. Por último, se creó un mapa estandarizado de la tasa de morbilidad para evaluar la distribución geográfica de la ON en el país.

Resultados: De 2015 a 2019, se notificaron 2.463 nuevos casos de ON. La tasa de incidencia global a 5 años fue de 1,56 casos por 100.000 habitantes y año, siendo el 66% de los pacientes mujeres. El pico de presentación en varones fue el quinquenio de 50-54 años, y en mujeres, el de 45-49 años. En 2020, coincidiendo con la pandemia de COVID-19, se produjo una reducción de la incidencia de ON de aproximadamente 0,15 casos por 100.000 habitantes. Las regiones con alto número de casos y riesgo creciente de nuevos casos fueron Bogotá, Antioquia y Valle del Cauca.

Conclusiones: La incidencia de ON en Colombia es menor comparada con países del hemisferio norte, predominando la afectación en mujeres menores de 50 años. El inicio de la pandemia de COVID-19 se correspondió con una reducción en la identificación de nuevos casos de ON. Esto subraya la necesidad de que los gobiernos implementen estrategias diagnósticas efectivas en el futuro.

Título traducido de la contribución	Estudio Epidemiológico Colombiano de Enfermedades Inflamatorias Oculares (COIDES): Incidencia de la neuritis óptica entre 2015 y 2020
Idioma original	Inglés estadounidense
Publicación	Ocular Immunology and Inflammation
DOI	https://doi.org/10.1080/09273948.2023.2295538
Estado	Publicación electrónica previa a su impresión - dic. 22 2023

Áreas temáticas de ASJC Scopus

Inmulogía y alergología
Oftalmología

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1080/09273948.2023.2295538

Otros archivos y enlaces

Citar esto

Rodríguez-Rodríguez, C. A., Cifuentes-González, C., Mejía-Salgado, G., Garzón-Dangond, J. M., Verbel-Yaneth, A. V., Machado-Galindo, S., Cruz-Reyes, D. L., & de-la-Torre, A. (2023). Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES): Optic Neuritis Incidence Between 2015-2020. Ocular Immunology and Inflammation. Avanzar publicación online. https://doi.org/10.1080/09273948.2023.2295538

@article{459286efe621403894dd00e0aa170067,

title = "Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES): Optic Neuritis Incidence Between 2015-2020",

abstract = "Purpose: To estimate the incidence of Optic Neuritis (ON) in Colombia using data from the national health registry between January 1, 2015, and December 31, 2020. Methods: A population-based study was conducted using the Integrated Social Protection Information System from the Colombian Ministry of Health and the International Classification of Diseases-10 code for ON to estimate the incidence of ON from 2015 to 2020. We also evaluated the impact of the COVID-19 lockdown on the epidemiology of the disease in 2020. Finally, a standardized morbidity rate map was created to assess a country{\textquoteright}s ON geographic distribution. Results: From 2015 to 2019, 2,463 new cases of ON were reported. The overall 5-year incidence rate was 1.56 cases per 100,000 inhabitants per year, 66% of the patients were females. The peak of presentation in males was the quinquennium of 50–54 years, and in females, it was 45–49 years. In 2020, coinciding with the COVID-19 pandemic, there was a reduction in the incidence of ON by approximately 0.15 cases per 100,000 inhabitants. The regions with a high number of cases and an increasing risk of new cases were Bogot{\'a}, Antioquia, and Valle del Cauca. Conclusions: The incidence of ON in Colombia is lower compared to countries in the northern hemisphere, with women under 50 years being predominantly affected. The onset of the COVID-19 pandemic corresponded with a reduction in identifying new ON cases. This underscores governments{\textquoteright} need to implement effective diagnostic strategies in the future.",

author = "Rodr{\'i}guez-Rodr{\'i}guez, {Camilo Andr{\'e}s} and Carlos Cifuentes-Gonz{\'a}lez and Germ{\'a}n Mej{\'i}a-Salgado and Garz{\'o}n-Dangond, {Juan Manuel} and Verbel-Yaneth, {Angie Vanessa} and Sofia Machado-Galindo and Cruz-Reyes, {Danna Lesley} and Alejandra de-la-Torre",

note = "Publisher Copyright: {\textcopyright} 2023 Taylor & Francis Group, LLC.",

year = "2023",

month = dec,

day = "22",

doi = "10.1080/09273948.2023.2295538",

language = "English (US)",

journal = "Ocular Immunology and Inflammation",

issn = "0927-3948",

publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES)

T2 - Optic Neuritis Incidence Between 2015-2020

AU - Rodríguez-Rodríguez, Camilo Andrés

AU - Cifuentes-González, Carlos

AU - Mejía-Salgado, Germán

AU - Garzón-Dangond, Juan Manuel

AU - Verbel-Yaneth, Angie Vanessa

AU - Machado-Galindo, Sofia

AU - Cruz-Reyes, Danna Lesley

AU - de-la-Torre, Alejandra

PY - 2023/12/22

Y1 - 2023/12/22

N2 - Purpose: To estimate the incidence of Optic Neuritis (ON) in Colombia using data from the national health registry between January 1, 2015, and December 31, 2020. Methods: A population-based study was conducted using the Integrated Social Protection Information System from the Colombian Ministry of Health and the International Classification of Diseases-10 code for ON to estimate the incidence of ON from 2015 to 2020. We also evaluated the impact of the COVID-19 lockdown on the epidemiology of the disease in 2020. Finally, a standardized morbidity rate map was created to assess a country’s ON geographic distribution. Results: From 2015 to 2019, 2,463 new cases of ON were reported. The overall 5-year incidence rate was 1.56 cases per 100,000 inhabitants per year, 66% of the patients were females. The peak of presentation in males was the quinquennium of 50–54 years, and in females, it was 45–49 years. In 2020, coinciding with the COVID-19 pandemic, there was a reduction in the incidence of ON by approximately 0.15 cases per 100,000 inhabitants. The regions with a high number of cases and an increasing risk of new cases were Bogotá, Antioquia, and Valle del Cauca. Conclusions: The incidence of ON in Colombia is lower compared to countries in the northern hemisphere, with women under 50 years being predominantly affected. The onset of the COVID-19 pandemic corresponded with a reduction in identifying new ON cases. This underscores governments’ need to implement effective diagnostic strategies in the future.

AB - Purpose: To estimate the incidence of Optic Neuritis (ON) in Colombia using data from the national health registry between January 1, 2015, and December 31, 2020. Methods: A population-based study was conducted using the Integrated Social Protection Information System from the Colombian Ministry of Health and the International Classification of Diseases-10 code for ON to estimate the incidence of ON from 2015 to 2020. We also evaluated the impact of the COVID-19 lockdown on the epidemiology of the disease in 2020. Finally, a standardized morbidity rate map was created to assess a country’s ON geographic distribution. Results: From 2015 to 2019, 2,463 new cases of ON were reported. The overall 5-year incidence rate was 1.56 cases per 100,000 inhabitants per year, 66% of the patients were females. The peak of presentation in males was the quinquennium of 50–54 years, and in females, it was 45–49 years. In 2020, coinciding with the COVID-19 pandemic, there was a reduction in the incidence of ON by approximately 0.15 cases per 100,000 inhabitants. The regions with a high number of cases and an increasing risk of new cases were Bogotá, Antioquia, and Valle del Cauca. Conclusions: The incidence of ON in Colombia is lower compared to countries in the northern hemisphere, with women under 50 years being predominantly affected. The onset of the COVID-19 pandemic corresponded with a reduction in identifying new ON cases. This underscores governments’ need to implement effective diagnostic strategies in the future.

UR - http://www.scopus.com/inward/record.url?scp=85180199243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85180199243&partnerID=8YFLogxK

U2 - 10.1080/09273948.2023.2295538

DO - 10.1080/09273948.2023.2295538

M3 - Article

C2 - 38133944

AN - SCOPUS:85180199243

SN - 0927-3948

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

ER -

Colombian Ocular Inflammatory Diseases Epidemiology Study (COIDES): Optic Neuritis Incidence Between 2015-2020

Resumen

Áreas temáticas de ASJC Scopus

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto